How many institutions own VRAX stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own VRAX shares is 7, representing 4.31% of the company's common stock.

Who are the major shareholders selling Virax Biolabs Group Limited stock?

VIRTU FINANCIAL LLC, in the last quarter, reduced its stake in VRAX by -100% restricting it's holding to 0 shares of worth nearly -. HRT FINANCIAL LP also lessened -100% of the VRAX shares from its portfolio, reducing its holding to 0 shares of worth -. NATIONAL BANK OF CANADA /FI/ also shunned VRAX shares holding by -40% last quarter which brought its holding to 6 thousand shares worth $2.07K.

Investors who are buying VRAX stock?

As per its latest 13F filing, UBS GROUP AG increased its stake in VRAX by 122.98% in the last quarter. The institutional holder raised its holding to 7.49 thousand shares having worth more than $2.59K. ADVISOR GROUP HOLDINGS, INC. also added 100% more shares of VRAX to its portfolio, raising its holding to 20 shares of worth $7.00. XTX TOPCO LTD also increased its VRAX shares holding by 100% which brought its holding to 21.44 thousand shares worth $7.41K.

VRAX's major insiders: who are they?

The insider with the most stakes in VRAX is N/A , N/A at the company. Additionally, VRAX stock is highly held by N/A N/A and N/A N/A among others.

Did an insider recently sell VRAX stock?

Company executives, directors, and other insiders own 1.79% percent of Virax Biolabs Group Limited's stock. Within the last six months, there have been 0 transaction(s) in which VRAX insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .

Which insider recently purchased VRAX stock?

There have been 0 transaction(s) during the past 6-months in which Virax Biolabs Group Limited insiders have bought stock, totalling 0 shares

How much of VRAX does insiders own?

Around 0 Virax Biolabs Group Limited shares are held by insiders, which represents about 1.79% of VRAX stock.

Who is the insider with the largest stake?

VRAX N/A, N/A holds the largest portfolio of the company's shares. VRAX shares owned by N/A total nearly -.

Which institution holds the most shares in VRAX?

UBS GROUP AG is the largest institutional owner in VRAX which holds 7.49 thousand shares worth $2.59K or 0.16% of the total VRAX shares outstanding followed by VIRTU FINANCIAL LLC with ownership of 0 shares representing 0% of the VRAX ownership. ADVISOR GROUP HOLDINGS, INC. is the third largest stakeholder with 20 shares or 0% of the ownership worth more than $7.00.

Is Virax Biolabs Group Limited stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the VRAX is concerned, it is a stock which is not optionable.

Is there a short position on VRAX's shares?

Number of VRAX shares short is 350.86K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding VRAX shares are there?

As of today, 4.34M shares of VRAX are outstanding.

Is there many float in VRAX stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, VRAX has 3.68M shares in float.

VRAX short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for VRAX is 0.31.

Stock Ideas

VRAX Stock Ownership Breakdown

NASDAQ : VRAX

Virax Biolabs Group

$0.24

0.0815+53.09%

At Close 4:00 PM

$0.28

+0.0408+17.36%

After-Market 08:30 PM

62.89

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableYes

OptionableNo

Short Percent Of Outstanding Shares8.08

Short Percent Of Float8.99

Shares Outstanding4.34M

Shares Float3.68M

Shares Short350.86K

Short Ratio0.31

8.99%

Short % of Float

8.08%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

1.79% Percentage of Shares held by All Insiders

4.31% Percentage of Shares held by All Institutions

4.39% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 4.31% of VRAX shares are held by financial institutions. UBS GROUP AG is the top corporate investor, holding 7.49K shares valued at $2.59K. A 0.16% stake in Virax Biolabs Group Limited is owned by the company. VIRTU FINANCIAL LLC owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Dec 31, 2025	UBS GROUP AG	0.16%	7.49K	2.59K	4.13K	+122.98%
Dec 31, 2025	VIRTU FINANCIAL LLC	0%	0	-	-21.38K	-100.00%
Dec 31, 2025	ADVISOR GROUP HOLDINGS, INC.	0%	20	7	20	+100.00%
Dec 31, 2025	XTX TOPCO LTD	0.45%	21.44K	7.41K	21.44K	+100.00%
Dec 31, 2025	HRT FINANCIAL LP	0%	0	-	-60.07K	-100.00%
Dec 31, 2025	NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO	0%	10	3	10	+100.00%
Dec 31, 2025	NATIONAL BANK OF CANADA /FI/	0.13%	6K	2.07K	-4K	-40.00%
Sep 30, 2025	CITADEL ADVISORS LLC	0%	0	-	-30.16K	-100.00%
Sep 30, 2025	UBS GROUP AG	0.11%	3.36K	2.04K	3.36K	+100.00%
Sep 30, 2025	NATIONAL BANK OF CANADA /FI/	0.32%	10K	6K	5K	+100.00%
Sep 30, 2025	VIRTU FINANCIAL LLC	0.69%	21.38K	13K	21.38K	+100.00%
Sep 30, 2025	HRT FINANCIAL LP	1.94%	60.07K	36K	60.07K	+100.00%
Jun 30, 2025	CITADEL ADVISORS LLC	0.97%	30.16K	24.67K	16.62K	+122.73%
Jun 30, 2025	NATIONAL BANK OF CANADA /FI/	0.16%	5K	3.95K	5K	+100.00%
Jun 30, 2025	TWO SIGMA SECURITIES, LLC	0%	0	-	-13.63K	-100.00%
Jun 30, 2025	HRT FINANCIAL LP	0%	0	-	-13.51K	-100.00%
Jun 30, 2025	UBS GROUP AG	0%	0	-	-22.43K	-100.00%
Mar 31, 2025	TOWER RESEARCH CAPITAL LLC (TRC)	0%	0	-	-9	-100.00%
Mar 31, 2025	XTX TOPCO LTD	0%	0	-	-11.86K	-100.00%
Mar 31, 2025	ROYAL BANK OF CANADA	0%	0	-	-10.4K	-100.00%
Mar 31, 2025	MORGAN STANLEY	0%	0	-	-100	-100.00%
Mar 31, 2025	HRT FINANCIAL LP	0.44%	13.51K	15K	13.51K	+100.00%
Mar 31, 2025		0%	0	-	-2.7K	-100.00%
Mar 31, 2025	CITADEL ADVISORS LLC	0.44%	13.54K	15.43K	13.54K	+100.00%
Mar 31, 2025	NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO	0%	0	-	-20	-100.00%
Mar 31, 2025	TWO SIGMA SECURITIES, LLC	0.44%	13.63K	15.54K	13.63K	+100.00%
Mar 31, 2025	UBS GROUP AG	0.72%	22.43K	25.57K	-15.49K	-40.85%
Sep 30, 2023	MILLENNIUM MANAGEMENT LLC	0%	0	-	-12.58K	-100.00%
Sep 30, 2023	RENAISSANCE TECHNOLOGIES LLC	0%	0	-	-24.6K	-100.00%
Sep 30, 2023	SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.13%	15K	4.88K	15K	+100.00%
Sep 30, 2023	UBS GROUP AG	0%	147	48	147	+100.00%
Sep 30, 2023	WELLS FARGO & COMPANY/MN	0.02%	2K	650	0	0
Sep 30, 2023	CITADEL ADVISORS LLC	0.14%	16.36K	5.32K	16.36K	+100.00%
Sep 30, 2023	TWO SIGMA SECURITIES, LLC	0%	0	-	-18.16K	-100.00%

Frequently Asked Questions

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.